Investment Trust Insider on Bluefield Solar – James Carthew: the high-yield solar fund basking in UK’s rays With the ‘Beast from the East’ receding it is time to think about spring and sunshine, specifically Bluefield Solar Income Fund (BSIF), the only one of the renewable energy investment companies I own. It has been a great […]
James Carthew: doctor your portfolio with a GP landlord Primary Healthcare Properties (PHP) last week announced results for the year to 31 December 2017. It is one of three listed funds investing in GP surgeries and other primary healthcare facilities in the UK and Ireland, the others being MedicX (MXF) and Assura (AGR). Most of […]
James Carthew: ouch! Watch out for key manager risk Events of the past couple of weeks have highlighted the impact that the departure of a manager can have on the rating of a trust. First, we heard that Carlos Hardenberg is to leave Franklin Templeton and then Philip Rodrigs was ousted from River & Mercantile. […]
James Carthew: RDI’s re-defining bet on London offices When a market experiences fundamental change it can be hard to separate cyclical and secular growth drivers. Or, to put it another way, the market for offices in London is changing and I’m not sure how much of this is down to changes in the way that […]
James Carthew: where is a US growth trust when you want it? One of the strangest things about investment companies is how under-represented the US stock market is within the sector. Dedicated listed North American funds accounted for just 1.6% of the money in investment trusts and investment companies at the end of last year, […]
James Carthew: don’t bet the house on reinsurance casino 2017 was one of the worst years on record for natural catastrophes. Three massive hurricanes (Harvey, Irma and Maria), two typhoons (Hato and Tembin), cyclone Debbie, California wildfires, monsoon flooding in South Asia, earthquakes in Iran, Iraq and Mexico and landslides in Sierra Leone and Peru […]
James Carthew of QuotedData provides comment to Mike Sheen of Investment Week on new EM management line-up at Franklin Templeton. Manraj Sekhon appointment as CIO of emerging markets equity coincides with a raft of changes in the asset class’s senior leadership team, which will be organised by strategy type, with directors overseeing global emerging markets, […]
Investment Trust Insider on Scottish Mortgage – The investment company industry had a good 2017. Money flooded into the sector; we got a couple of new and potentially fast-growing sub-sectors in the form of social housing and biotech debt; discounts narrowed; and, in general, performance was pretty good. By my reckoning, the average equity-focused investment […]
Investment Trust Insider – trusts that didn’t escape me last year. As 2018 gets underway, I thought that it might be worth revisiting some of the funds that I wrote about in 2017. At the start of the year I hailed the changes that Standard Life Private Equity (SLPE) was implementing to broaden its investment proposition and noted the increasing […]
Investment Trust Insider on Biotech – inspired by the launch of our biotech news service on QuotedData, I wrote something for Citywire that looks at some of the exciting stories that have been published just in the last couple of weeks. James Carthew: biotech boom boosts generalist trusts This week I am returning to the […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated